Kashyap Tele Medicines Ltd Stock Price Today (NSE: KASHYAP)

Kashyap Tele Medicines Ltd

5.55+0.00 (+0.00%)
Market Open

Fundamental Score

...

Kashyap Tele Medicines Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Kashyap Tele Medicines Ltd share price today is 5.55, up +0.00% on NSE/BSE as of 17 June 2026. Kashyap Tele Medicines Ltd (KASHYAP) is a Small-cap company in the IT Enabled Services sector with a market capitalisation of 45.19 (Cr). The 52-week high for KASHYAP share price is 12.50 and the 52-week low is 4.20. 0

Kashyap Tele Medicines Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
5.55
Low
5.04
Volume
6.3K
Change
+4.96%

Kashyap Tele Medicines Ltd share price chart: 4.96% return over the past month. 52-week high ₹12.50, 52-week low ₹4.20.

Kashyap Tele Medicines Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
5.295.295.295.29974.00 (Cr)
5.295.295.295.290.00 (Cr)
5.295.295.295.290.00 (Cr)
5.295.295.295.290.00 (Cr)
5.295.295.295.290.00 (Cr)
5.295.295.295.299.18K (Cr)
5.295.295.295.293.22K (Cr)
5.295.295.295.293.92K (Cr)
5.045.045.045.0410.25K (Cr)
5.045.045.045.045.00K (Cr)

Kashyap Tele Medicines Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
5.295.295.295.29+0.00%
5.045.295.045.29+4.96%
5.045.045.045.04+0.00%
5.105.104.205.04-1.18%
6.196.195.325.32-14.05%
7.587.586.516.51-14.12%
8.909.757.617.97-10.45%
10.2411.808.839.36-8.59%
10.2912.509.8510.44+1.46%
8.9210.228.739.81+9.98%
7.189.916.909.10+26.74%
7.688.407.177.18-6.51%

Returns & Performance

Poor

Return on Equity (ROE)

0.00%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

0.00%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

-13.40%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Kashyap Tele Medicines Ltd Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

33.81x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

61.93%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.06%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Profit Growth (Quarterly YoY)

N/A

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-100.00%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

-1.02%

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.00x

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-0.10 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Kashyap Tele Medicines Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of KASHYAP across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Balanced Promoter Holding (61.93%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

8 factors identified

Below-Average Return on Equity (0.00%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (0.00%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (-13.40%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Revenue Contraction (-100.00%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Limited Growth History (-1.02% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Negative Free Cash Flow (₹-0.10 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 0.06%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Kashyap Tele Medicines Ltd vs IT Enabled Services Peers

Peer Comparison - IT Enabled Services

Compare Kashyap Tele Medicines Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
8/100
6
₹45.19
0.00%
Poor
0.00%
Poor
0.0
Excellent
-1.02%
Poor
0.00%
56.4/100
3396
₹47130.29
36.9
Average
22.16%
Excellent
28.29%
Excellent
0.1
Excellent
9.04%
Good
13.68%
Good
1.24%
65.2/100
1640
₹29262.67
48.0
Average
32.87%
Excellent
27.20%
Excellent
0.3
Excellent
28.66%
Excellent
38.17%
Excellent
0.00%
55.6/100
715
₹27600.58
39.8
Average
19.91%
Good
25.80%
Excellent
0.1
Excellent
21.37%
Excellent
12.63%
Good
1.23%
66.3/100
1441
₹23851.31
56.9
Average
14.03%
Average
16.82%
Good
0.0
Excellent
42.26%
Excellent
46.68%
Excellent
0.00%
41.7/100
40
₹23303.54
29.2
Average
7.38%
Poor
9.58%
Poor
0.1
Excellent
0.10%
60/100
4625
₹18241.54
135.3
Average
23.93%
Excellent
32.45%
Excellent
0.0
Excellent
96.32%
Excellent
49.09%
Excellent
0.08%
Cyient Ltd...
CYIENT532175
37/100
905
₹12937.90
22.9
Average
12.81%
Average
16.58%
Good
0.1
Excellent
12.34%
Good
10.70%
Good
2.24%
42.7/100
1047
₹9185.65
33.8
Average
44.23%
Excellent
29.75%
Excellent
1.1
Average
23.39%
Excellent
3.62%
Average
0.19%
62.7/100
205
₹5175.87
46.5
Average
9.60%
Poor
12.99%
Average
0.0
Excellent
88.05%
Excellent
80.32%
Excellent
0.00%
63.5/100
1260
₹5101.67
17.9
Average
25.96%
Excellent
34.09%
Excellent
0.0
Excellent
12.67%
Good
18.23%
Excellent
0.00%

Kashyap Tele Medicines Ltd Quarterly Performance

Latest quarterly metrics for KASHYAP — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-100.00%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

N/A

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

-1.02%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Kashyap Tele Medicines Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for KASHYAP — calculated from daily price history

85RSI 14
Overbought — RSI 85

Momentum is strong — price may be stretched. Watch for pullbacks.

SMA 50
7
▼ Price below SMA 50 — Short-term bearish
SMA 200
8
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
16K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Kashyap Tele Medicines Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Kashyap Tele Medicines Ltd (KASHYAP) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Kashyap Tele Medicines Ltd

About KASHYAP (Kashyap Tele Medicines Ltd)

Kashyap Tele Medicines Ltd is a pioneering force in the Indian IT-Enabled Services sector, dedicated to revolutionizing healthcare accessibility and efficiency through innovative t...echnology solutions. We specialize in developing and deploying cutting-edge telemedicine platforms, enabling remote consultations, diagnostics, and patient monitoring. Our core competency lies in seamlessly integrating complex medical data with user-friendly interfaces, ensuring both healthcare professionals and patients can navigate the system with ease. Beyond the virtual consultation room, we offer comprehensive data analytics services, empowering healthcare providers with actionable insights to optimize resource allocation, improve treatment outcomes, and proactively manage population health. We are committed to bridging the geographical divide and democratizing access to quality healthcare for all. Our service portfolio encompasses a broad spectrum of technology solutions tailored to the unique needs of the healthcare industry. We provide secure and compliant data storage and management systems, adhering to the highest standards of patient privacy and data integrity. Our software development team is adept at creating custom applications for various medical specialties, streamlining workflows, and enhancing clinical decision support. We also offer robust IT infrastructure management, ensuring the seamless operation of healthcare facilities and minimizing disruptions to patient care. Moreover, we provide comprehensive training programs for healthcare professionals, equipping them with the skills and knowledge necessary to effectively utilize our telemedicine platforms and embrace the digital transformation of healthcare. Kashyap Tele Medicines Ltd is driven by a singular vision: to transform healthcare delivery through technology. We are committed to continuous innovation, constantly exploring new possibilities to enhance the effectiveness, efficiency, and accessibility of healthcare services. We foster a collaborative environment, bringing together a team of talented IT professionals, medical experts, and business strategists to develop and deploy impactful solutions. By leveraging the power of IT, we strive to empower healthcare providers, improve patient outcomes, and ultimately build a healthier and more equitable future for all. Our focus remains steadfast on delivering reliable, secure, and scalable telemedicine solutions that make a tangible difference in the lives of people across India and beyond.

Company Details

Symbol:KASHYAP
Industry:IT Enabled Services
Sector:IT Enabled Services

Key Leadership

Mr. Kalpesh Bipin Sheth
MD & Executive Director
Mr. Anirudh Shah
Chief Financial Officer
Ms. Varsha Sawant
Company Secretary & Compliance Officer

KASHYAP Share Price: Frequently Asked Questions

What is the current share price of Kashyap Tele Medicines Ltd?

Kashyap Tele Medicines Ltd (KASHYAP) trades at ₹5.55 on NSE and BSE. Market cap ₹45.19 (Cr). Educational data only.

What is the P/E ratio of Kashyap Tele Medicines Ltd?

Kashyap Tele Medicines Ltd has a P/E of N/Ax vs industry average 33.81x.

What is the Bull Run score for Kashyap Tele Medicines Ltd?

Kashyap Tele Medicines Ltd has a Bull Run score of 8/100 based on 25+ financial parameters.

Does Kashyap Tele Medicines Ltd pay dividends?

Kashyap Tele Medicines Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Kashyap Tele Medicines Ltd?

Kashyap Tele Medicines Ltd has ROE of 0.00%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Kashyap Tele Medicines Ltd?

Kashyap Tele Medicines Ltd has debt-to-equity of 0.00.

Is Kashyap Tele Medicines Ltd a good investment?

Bull Run gives Kashyap Tele Medicines Ltd a score of 8/100. This is not investment advice — consult a SEBI-registered advisor.